Meprobamate and Drug toxicity - a phase IV clinical study of FDA data
Drug toxicity is found among people who take Meprobamate, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Meprobamate and have Drug toxicity. It is created by eHealthMe based on reports of 2,126 people who have side effects when taking Meprobamate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
2,126 people reported to have side effects when taking Meprobamate.
Among them, 175 people (8.23%) have Drug toxicity.
What is Meprobamate?
Meprobamate has active ingredients of meprobamate. It is often used in stress and anxiety. eHealthMe is studying from 2,149 Meprobamate users for its effectiveness, alternative drugs and more.
What is Drug toxicity?
Drug toxicity is found to be associated with 1,679 drugs and 1,312 conditions by eHealthMe.
Number of Meprobamate and Drug toxicity reports submitted per year:
Time on Meprobamate when people have Drug toxicity *:
Gender of people who have Drug toxicity when taking Meprobamate*:
Age of people who have Drug toxicity when taking Meprobamate *:
Common drugs people take besides Meprobamate *:
Common side effects people have besides Drug toxicity *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Meprobamate and have Drug toxicity?Check whether Drug toxicity is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
Alternative drugs to, pros and cons of Meprobamate:
- Meprobamate (2,149 reports)
Drug toxicity treatments and more:
- Drug toxicity (20,258 reports)
COVID vaccines that are related to Drug toxicity:
- Drug toxicity in Moderna COVID Vaccine
- Drug toxicity in Pfizer BioNTech Covid Vaccine
- Drug toxicity in Johnson and Johnson Covid Vaccine
How severe was Drug toxicity and when was it recovered:
Expand to all the drugs that have ingredients of meprobamate:
- Drug toxicity and drugs with ingredients of meprobamate (197 reports)
Common drugs associated with Drug toxicity:
All the drugs that are associated with Drug toxicity:
- Drug toxicity (1,679 drugs)
Common conditions associated with Drug toxicity:
All the conditions that are associated with Drug toxicity:
- Drug toxicity (1,312 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on meprobamate (the active ingredients of Meprobamate) and Meprobamate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zovia 1/35E-21 vs. Micronor - 2 seconds ago
- Efavirenz and Adalat drug interaction - 4 seconds ago
- Synthroid and White Blood Cell Count Decreased - 5 seconds ago
- Atorvastatin Calcium and Mycostatin drug interaction - 10 seconds ago
- Rifampin and Glyburide drug interaction - 15 seconds ago